Weight loss and coronary heart disease: Sensitivity analysis for unmeasured confounding by undiagnosed disease

Epidemiology

Volumn 27, Issue 2, 2016, Pages 302-310

  Danaei, Goodarz ^a   Robins, James M ^a   Young, Jessica G ^a   Hu, Frank B ^a,b   Manson, Joann E ^a,b   Hernán, Miguel A ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MULTIVITAMIN;

ADULT; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANGINA PECTORIS; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; DEPRESSION; DIABETES MELLITUS; EMPHYSEMA; EXERCISE; FEMALE; FOLLOW UP; GOUT; HEART FAILURE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; PARKINSON DISEASE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS; WEIGHT REDUCTION; BODY MASS; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; MORTALITY; OBESITY; OVERWEIGHT; RISK FACTOR; STATISTICAL MODEL; STATISTICS;

ADULT; BODY MASS INDEX; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; OBESITY; OVERWEIGHT; RISK FACTORS; STATISTICS AS TOPIC; WEIGHT LOSS;

EID: 84957435953     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0000000000000428     Document Type: Article

References (37)

1. Stevens GA, Singh GM, Lu Y, et al.; global Burden of Metabolic risk Factors of chronic Diseases collaborating group (Body Mass index). national, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr. 2012;10:22.
2. Wormser D, Kaptoge S, Di Angelantonio E, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011;377:1085-1095.
3. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med. 1995;333:677-685.
4. Galanis DJ, Harris T, Sharp DS, Petrovitch H. relative weight, weight change, and risk of coronary heart disease in the Honolulu Heart Program. Am J Epidemiol. 1998;147:379-386.
5. Mikkelsen KL, Heitmann BL, Keiding N, Sørensen TI. Independent effects of stable and changing body weight on total mortality. Epidemiology. 1999;10:671-678.
6. Nilsson PM, Nilsson JA, Hedblad B, Berglund G, Lindgärde F. The enigma of increased non-cancer mortality after weight loss in healthy men who are overweight or obese. J Intern Med. 2002;252:70-78.
7. Lee IM, Paffenbarger RS Jr. change in body weight and longevity. JAMA. 1992;268:2045-2049.
8. Nanri A, Mizoue T, Takahashi Y, Noda M, Inoue M, Tsugane S; Japan Public Health center- based Prospective Study group. Weight change and all-cause, cancer and cardiovascular disease mortality in Japanese men and women: the Japan Public Health center-Based Prospective Study. Int J Obes (Lond). 2010;34:348-356.
9. French SA, Folsom AR, Jeffery RW, Williamson DF. Prospective study of intentionality of weight loss and mortality in older women: the iowa Women's Health Study. Am J Epidemiol. 1999;149:504-514.
10. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C. Prospective study of intentional weight loss and mortality in overweight white men aged 40-64 years. Am J Epidemiol. 1999;149:491-503.
11. Gregg E W, Gerzoff RB, Thompson TJ, Williamson D F. intentional weight loss and death in overweight and obese U.S. adults 35 years of age and older. Ann Intern Med. 2003;138:383-389.
12. Wannamethee SG, Shaper AG, Walker M. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes. J Epidemiol Community Health. 2005;59:134-139.
13. Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307:56-65.
14. Adams TD, Gress RE, Smith SC, et al. long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753-761.
15. Taubman SL, Robins JM, Mittleman MA, Hernán M.A. intervening on risk factors for coronary heart disease: an application of the parametric g-formula. Int J Epidemiol. 2009;38:1599-1611.
16. Robins JM. causal models for estimating the effects of weight gain on mortality. Int J Obes (Lond). 2008;32 Suppl 3:S15-S41.
17. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343:16-22.
18. Willett W, Stampfer MJ, Bain C, et al. cigarette smoking, relative weight, and menopause. Am J Epidemiol. 1983;117:651-658.
19. Danaei G, Pan A, Hu FB, Hernán M.A. Hypothetical midlife interventions in women and risk of type 2 diabetes. Epidemiology. 2013;24:122-128.
20. Lajous M, Willett WC, Robins J, et al. changes in fsh consumption in midlife and the risk of coronary heart disease in men and women. Am J Epidemiol. 2013;178:382-391.
21. Hubert HB, Feinleib M, Mcnamara PM, Castelli W P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968-977.
22. Tirosh A, Shai I, Afek A, et al. Adolescent BM Itrajectory and risk of diabetes versus coronary disease. N Engl J Med. 2011;364:1315-1325.
23. Wildman R P, Schott LL, Brockwell S, Kuller LH, Sutton-tyrrell K. a dietary and exercise intervention slows menopause-associated progression of subclinical atherosclerosis as measured by intima-media thickness of the carotid arteries. J Am Coll Cardiol. 2004;44:579-585.
24. Kuller LH, Pettee Gabriel KK, Kinzel LS, et al. the women on the move through activity and nutrition (WOMan) study: fnal 48-month results. Obesity (Silver Spring). 2012;20:636-643.
25. Nissen SE, Nicholls SJ, Wolski K, et al.; Stradivarius investigators. effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the StraDiVariUS randomized controlled trial. JAMA. 2008;299:1547-1560.
26. O'leary DH, Reuwer AQ, Nissen SE, et al.; aUDitOr investigators. effect of rimonabant on carotid intima-media thickness (ciMt) progression in patients with abdominal obesity and metabolic syndrome: the Auditor trial. Heart. 2011;97:1143-1150.
27. James W P, Caterson ID, Coutinho W, et al.; SCOUT investigators. effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med. 2010;363:905-917.
28. Gardner CD, Kiazand A, Alhassan S, et al. comparison of the atkins, Zone, Ornish, and learn diets for change in weight and related risk factors among overweight premenopausal women: the a tO Z weight loss study: a randomized trial. JAMA. 2007;297:969-977.
29. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program research group. reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
30. Wing RR, Bolin P, Brancati FL, et al. cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145-154.
31. Robins JM, Hernán M.A. estimation of the causal effects of time-varying exposures. in: Fitzmaurice g, Davidian M, Verbeke g, Monenberghs g, eds. Longitudinal Data Analysis. Handbooks of Modern Statistical Methods. Boca raton, Fl: chapman & Hall/crc; 2009:553-599.
32. Robins JM, Hernán MA, Seibert U. effects of multiple interventions. in: ezzati M, lopez aD, rodgers a, Murray cJ, eds. Comparative Quantifcation of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors, Vol. 2. geneva, Switzerland: WHO; 2004:2191-2230.
33. Sjöström L, Lindroos AK, Peltonen M, et al.; Swedish Obese Subjects Study Scientifc group. lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-2693.
34. Saeidi N, Meoli L, Nestoridi E, et al. reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science. 2013;341:406-410.
35. Hernán M.A. invited commentary: hypothetical interventions to de-fne causal effects-afterthought or prerequisite? Am J Epidemiol. 2005;162:618-620; discussion 621.
36. Hernán MA, Taubman SL. Does obesity shorten life? the importance of well-defned interventions to answer causal questions. Int J Obes (Lond). 2008;32(Suppl 3):S8-S14.
37. Hernán MA, VanderWeele TJ. compound treatments and transportability of causal inference. Epidemiology. 2011;22:368-377.